132 related articles for article (PubMed ID: 20684596)
1. A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer.
Yan F; Cao XX; Jiang HX; Zhao XL; Wang JY; Lin YH; Liu QL; Zhang C; Jiang B; Guo F
J Med Chem; 2010 Aug; 53(15):5502-10. PubMed ID: 20684596
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.
Wang G; Nikolovska-Coleska Z; Yang CY; Wang R; Tang G; Guo J; Shangary S; Qiu S; Gao W; Yang D; Meagher J; Stuckey J; Krajewski K; Jiang S; Roller PP; Abaan HO; Tomita Y; Wang S
J Med Chem; 2006 Oct; 49(21):6139-42. PubMed ID: 17034116
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
Lin J; Wu Y; Yang D; Zhao Y
Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
[TBL] [Abstract][Full Text] [Related]
4. Chiral gossypol derivatives: evaluation of their anticancer activity and molecular modeling.
Zhang L; Jiang H; Cao X; Zhao H; Wang F; Cui Y; Jiang B
Eur J Med Chem; 2009 Oct; 44(10):3961-72. PubMed ID: 19447525
[TBL] [Abstract][Full Text] [Related]
5. Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L).
Becattini B; Kitada S; Leone M; Monosov E; Chandler S; Zhai D; Kipps TJ; Reed JC; Pellecchia M
Chem Biol; 2004 Mar; 11(3):389-95. PubMed ID: 15123268
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of gossypol atropisomers and derivatives and evaluation of their anti-proliferative and anti-oxidant activity.
Dodou K; Anderson RJ; Lough WJ; Small DA; Shelley MD; Groundwater PW
Bioorg Med Chem; 2005 Jul; 13(13):4228-37. PubMed ID: 15878283
[TBL] [Abstract][Full Text] [Related]
7. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ
Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J; Kitada S; Stebbins JL; Placzek W; Zhai D; Wu B; Rega MF; Zhang Z; Cellitti J; Yang L; Dahl R; Reed JC; Pellecchia M
J Med Chem; 2010 Nov; 53(22):8000-11. PubMed ID: 21033669
[TBL] [Abstract][Full Text] [Related]
11. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF
Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693
[TBL] [Abstract][Full Text] [Related]
12. Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins.
Tang G; Nikolovska-Coleska Z; Qiu S; Yang CY; Guo J; Wang S
J Med Chem; 2008 Feb; 51(4):717-20. PubMed ID: 18237106
[TBL] [Abstract][Full Text] [Related]
13. A novel water-soluble heptaplatin analogue with improved antitumor activity and reduced toxicity.
Liu W; Chen X; Ye Q; Xu Y; Xie C; Xie M; Chang Q; Lou L
Inorg Chem; 2011 Jun; 50(12):5324-6. PubMed ID: 21598993
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of taxane-induced cytotoxicity and apoptosis by gossypol in human breast cancer cell line MCF-7.
Karaca B; Atmaca H; Uzunoglu S; Karabulut B; Sanli UA; Uslu R
J BUON; 2009; 14(3):479-85. PubMed ID: 19810142
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer activity of new 1-[(5 or 6-substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.
Lee YB; Gong YD; Yoon H; Ahn CH; Jeon MK; Kong JY
Bioorg Med Chem; 2010 Nov; 18(22):7966-74. PubMed ID: 20943401
[TBL] [Abstract][Full Text] [Related]
17. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
18. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of enantiomers of gossypol Schiff's bases and optical stability of gossypolone.
Dao VT; Dowd MK; Martin MT; Gaspard C; Mayer M; Michelot RJ
Eur J Med Chem; 2004 Jul; 39(7):619-24. PubMed ID: 15236842
[TBL] [Abstract][Full Text] [Related]
20. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]